Christoph Freiberg, GenData, Basel, Schweiz
We have implemented a dedicated cell line development platform for automating the generation, selection, and assessment of mammalian cell lines. By centrally capturing and processing all data along the CLD process, the system identifies high-yield cell lines showing the most promise for biopharmaceutical manufacturing.
By directly integrating with laboratory instruments, such as pipetting robots, colony pickers, bioreactors, and bioanalyzers, the platform streamlines all relevant laboratory operations such as seeding, selection, incubation, passaging, analyzing, and cryo-conservation. Co-developed with leading biopharmaceutical companies, the system tracks the full history of all clones, along with product quality and analytics data, significantly increasing process efficiency and quality. Selected use cases will be presented during this presentation.